From: First brachytherapy treatment of prostate cancer in Nigeria using low dose rate radioactive iodine 125
Risk group
Clinical stage
PSA
Gleason score
Low (0)
≤ T2b
AND
≤ 10
≤ 6
Intermediate (1)
> T2b
OR
> 10
> 6
High (≥ 2)
AND/OR